Japan Proton Therapy Markets, 2009-2018 & 2019-2025 by Patients of 10 Cancer Types & Reimbursement Policies & Persons Treated at Centers – ResearchAndMarkets.com
Rising cancer prevalence, increasing aging population, growing per capita expenditure, increasing number of proton therapy center in
Patients Insight - Japan Proton Therapy
This report contains full information about patients, who are likely to get treated with proton therapy, the actual number of patients who have received proton therapy treatment. Moreover we have also categorized the patients on the basis of disease or cancer type into 10 parts; Head and Neck Cancer, Central Nervous System (CNS) Tumors, GI (Gastro-Intestinal) Cancer, Hepatocellular Carcinoma (HCC), Pancreas Cancer, Prostate Cancer,
Market Insight - Japan Proton Therapy
This report on Japan Proton Therapy Market, Patients by 10 Cancer Types (Central Nervous System (CNS), Head and Neck, Lung, GI (Gastro-Intestinal), Hepatocellular Carcinoma (HCC), Pancreas, Gynecologic, Prostate, Bone and Soft Tissue, Others) Reimbursement Policies & Persons Treated at Centers provides a comprehensive assessment of the fast-evolving, high-growth of Japan Proton Therapy Market.
The report studies the market and patients numbers, of 10 individual cancer types who are treated under proton therapy. The report also talks about the list of all operational and future Proton Therapy centers; Reimbursement Policies. The report also studies the Proton Therapy Revenue of 3 Companies.
Types of Proton Therapy Market (Actual & Untapped)
1. Actual Market is the current market which is already present.
2. Untapped Market is the market which can be achieved, but it has yet not been achieved due to the demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year.
Key Topics Covered:
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market (Actual & Untapped) - Japan Proton Therapy (2009 - 2025)
4.1 Actual Proton Therapy Market
4.2 Untapped Proton Therapy Market
5. Number of Patients - Japan Proton Therapy (2009 - 2025)
5.1 Actual Numbers
5.2 Untapped Numbers
6. Cancer Types - Japan Proton Therapy Number of Patients (2009 - 2025)
6.1 Central Nervous System (CNS) Tumors
6.2 Head and Neck Cancer
6.3
6.4 GI (Gastro-Intestinal) Cancer
6.5 Hepatocellular Carcinoma (HCC) Cancer
6.6 Pancreas Cancer
6.7 Gynecologic Cancers
6.8 Prostate Cancer
6.9 Bone and Soft Tissue Cancer
6.10 Others Cancer
7. Cancer Types - Japan Proton Therapy Market (2009 - 2025)
7.1 Central Nervous System (CNS) Tumors
7.2 Head and Neck Cancer
7.3
7.4 GI (Gastro-Intestinal) Cancer
7.5 Hepatocellular Carcinoma (HCC) Cancer
7.6 Pancreas Cancer
7.7 Gynecologic Cancers
7.8 Prostate Cancer
7.9 Bone and Soft Tissue Cancer
7.10 Others Cancer
8.
8.1 Operating Proton Therapy Centers
8.2 Under-Construction Therapy Centers
9. By Centers - Number of Proton Therapy Patients Treated
9.1
9.2
9.3 Tsukuba (PMRC, 2)
9.4
9.5
9.6
9.7
9.8 Fukui City (
9.9 Nagoya PTC,
9.10
9.11
9.12
10. Reimbursement Policies - Japan Proton Therapy
11. Components of a
11.1 Type of Proton Accelerator
11.1.1 Synchrotrons (example: LLUMC at Loma Linda)
11.1.2 Cyclotrons (example: MGH Boston)
11.1.3 Synchrocyclotrons (examples: Orsay, Uppsala)
11.1.4 Linacs (
11.1.5 H-minus Synchrotrons
11.1.6 Separated Sector Cyclotrons
11.1.7 Superconducting Cyclotrons
11.1.8 Fast Cycling Synchrotron
11.2 Beam Transport System
11.3 Beam Delivery System
11.3.1 The Passive Scattering Technique
11.3.2 Beam Scanning
11.4 Type of Nozzle
11.4.1 Single Scattering
11.4.2 Double Scattering
11.4.3 Uniform Scanning Nozzle
11.4.4 Pencil Scanning Nozzle
11.5 Treatment Planning System
11.6 Image Viewers
11.7 Patient Positioning System (PPS)
11.8 Human Resource
12. Company Analysis (2014 - 2025)
12.1
12.1.1 Sales Analysis
12.2 Varian Medical Systems
12.2.1 Sales Analysis
12.3 Elekta
12.3.1 Sales Analysis
13. Proton Therapy - Driving Factors
13.1 Technology Advancement
13.1.1 Next-Generation Proton Technique
13.2 Growing Incidence of Cancer Patients in
14. Challenges
14.1
14.2 Operation Challenges
For more information about this report visit https://www.researchandmarkets.com/r/k2ciud
View source version on businesswire.com: https://www.businesswire.com/news/home/20190909005620/en/
ResearchAndMarkets.com
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For
For GMT Office Hours Call +353-1-416-8900
Source:
Arthur J. Gallagher & Co. Acquires Serna Insurance Agency
Homesite Group Incorporated Announces Appointment of Grace Meek as President and CEO of Homesite Underwriting Managers, Inc.
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News